BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33221766)

  • 1. Integrative analysis reveals novel driver genes and molecular subclasses of hepatocellular carcinoma.
    Yang L; Zhang Z; Sun Y; Pang S; Yao Q; Lin P; Cheng J; Li J; Ding G; Hui L; Li Y; Li H
    Aging (Albany NY); 2020 Nov; 12(23):23849-23871. PubMed ID: 33221766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
    Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.
    Gu DL; Chen YH; Shih JH; Lin CH; Jou YS; Chen CF
    World J Gastroenterol; 2013 Dec; 19(47):8873-9. PubMed ID: 24379610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report.
    Lü Y; Zhang J; Li L; Li S; Yang Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31990034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal Meta-Analysis of 1,494 Hepatocellular Carcinoma Samples Reveals Significant Impact of Consensus Driver Genes on Phenotypes.
    Chaudhary K; Poirion OB; Lu L; Huang S; Ching T; Garmire LX
    Clin Cancer Res; 2019 Jan; 25(2):463-472. PubMed ID: 30242023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic features.
    Li X; Xu W; Kang W; Wong SH; Wang M; Zhou Y; Fang X; Zhang X; Yang H; Wong CH; To KF; Chan SL; Chan MTV; Sung JJY; Wu WKK; Yu J
    Theranostics; 2018; 8(6):1740-1751. PubMed ID: 29556353
    [No Abstract]   [Full Text] [Related]  

  • 8. Multi-omic analyses of hepatocellular carcinoma to determine immunological characteristics and key nodes in gene-expression network.
    Wang Z; Zhang S
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues.
    Tantiwetrueangdet A; Panvichian R; Sornmayura P; Leelaudomlipi S; Macoska JA
    BMC Cancer; 2021 Mar; 21(1):295. PubMed ID: 33743635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression.
    Midorikawa Y; Yamamoto S; Tatsuno K; Renard-Guillet C; Tsuji S; Hayashi A; Ueda H; Fukuda S; Fujita T; Katoh H; Ishikawa S; Covington KR; Creighton CJ; Sugitani M; Wheeler DA; Shibata T; Nagae G; Takayama T; Aburatani H
    Cancer Res; 2020 Sep; 80(18):3810-3819. PubMed ID: 32641413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach.
    Gentilini D; Scala S; Gaudenzi G; Garagnani P; Capri M; Cescon M; Grazi GL; Bacalini MG; Pisoni S; Dicitore A; Circelli L; Santagata S; Izzo F; Di Blasio AM; Persani L; Franceschi C; Vitale G
    Oncotarget; 2017 Jun; 8(26):41890-41902. PubMed ID: 28514750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive genome-wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma.
    Cui H; Zhang Y; Zhang Q; Chen W; Zhao H; Liang J
    Cancer Med; 2017 Dec; 6(12):2932-2941. PubMed ID: 29047230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide DNA methylation analysis identifies candidate epigenetic markers and drivers of hepatocellular carcinoma.
    Zheng Y; Huang Q; Ding Z; Liu T; Xue C; Sang X; Gu J
    Brief Bioinform; 2018 Jan; 19(1):101-108. PubMed ID: 27760737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
    Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival.
    Roessler S; Long EL; Budhu A; Chen Y; Zhao X; Ji J; Walker R; Jia HL; Ye QH; Qin LX; Tang ZY; He P; Hunter KW; Thorgeirsson SS; Meltzer PS; Wang XW
    Gastroenterology; 2012 Apr; 142(4):957-966.e12. PubMed ID: 22202459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma.
    Lee M; Kim K; Kim SY; Jung SH; Yoon J; Kim MS; Park HC; Jung ES; Chung YJ; Lee SH
    Hum Pathol; 2018 Nov; 81():37-46. PubMed ID: 29949741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis.
    Mao R; Liu J; Liu G; Jin S; Xue Q; Ma L; Fu Y; Zhao N; Xing J; Li L; Qiu Y; Lin B
    Oncotarget; 2017 Apr; 8(16):26185-26199. PubMed ID: 28412734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of genomic and immunological profiles in Chinese and Western hepatocellular carcinoma populations.
    Li W; Wu H; Xu X; Zhang Y
    Aging (Albany NY); 2021 Apr; 13(8):11564-11594. PubMed ID: 33867349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of the Thioredoxin System and Thioredoxin-Domain-Containing Protein Family in Hepatocellular Carcinoma.
    Cho SY; Kim S; Son MJ; Rou WS; Kim SH; Eun HS; Lee BS
    Dig Dis Sci; 2019 Jan; 64(1):123-136. PubMed ID: 30288659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.